RET and non-small cell lung carcinoma: In comparison to the NSCLC RET fusion-positive cohort, the other solid tumors RET fusion-positive cohort had a significantly higher prevalence of Central and South American and East Asian (8.6% vs 16%, 11% vs 3.8%, respectively, P < 0.01; Table 1).